» Articles » PMID: 33476633

Recent Trends in Cancer Therapy: A Review on the Current State of Gene Delivery

Overview
Journal Life Sci
Publisher Elsevier
Date 2021 Jan 21
PMID 33476633
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer treatment has been always considered one of the most critical and vital themes of clinical issues. Many approaches have been developed, depending on the type and the stage of tumor. Gene therapy has the potential to revolutionize different cancer therapy. With the advent of recent bioinformatics technologies and genetic science, it become possible to identify, diagnose and determine the potential treatment using the technology of gene delivery. Several approaches have been developed and experimented in vitro and vivo for cancer therapy including: naked nucleic acids based therapy, targeting micro RNAs, oncolytic virotherapy, suicide gene based therapy, targeting telomerase, cell mediated gene therapy, and CRISPR/Cas9 based therapy. In this review, we present a straightforward introduction to cancer biology and occurrence, highlighting different viral and non-viral gene delivery systems for gene therapy and critically discussed the current and various strategies for cancer gene therapy.

Citing Articles

Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy.

Zhu M, Chen H, Chen X, Zhang Y, Chen X, Zhou B Pharmaceutics. 2025; 17(2).

PMID: 40006507 PMC: 11859493. DOI: 10.3390/pharmaceutics17020139.


DSCC1 Identified as Promising Tumor Biomarker and Potential Therapeutic Target Through Comprehensive Multi-omics Analysis and Experimental Validation.

Cheng W, Lin P Mol Biotechnol. 2025; .

PMID: 39992486 DOI: 10.1007/s12033-025-01404-w.


From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery.

Xie L, Gan F, Hu Y, Zheng Y, Lan J, Liu Y J Funct Biomater. 2025; 16(1).

PMID: 39852571 PMC: 11766108. DOI: 10.3390/jfb16010015.


Role of Mutation in the Development of Eleven Different Cancers.

Hosseingholi Nouri S, Nitturi V, Ledbetter E, English C, Lau S, Klisch T Cancers (Basel). 2025; 17(1.

PMID: 39796693 PMC: 11720051. DOI: 10.3390/cancers17010064.


Application of Carbon Nanomaterials to Enhancing Tumor Immunotherapy: Current Advances and Prospects.

Li Y, Xu Z, Qi Z, Huang X, Li M, Liu S Int J Nanomedicine. 2024; 19:10899-10915.

PMID: 39479174 PMC: 11524014. DOI: 10.2147/IJN.S480799.